Literature DB >> 34231115

White matter hyperintensity volumes are related to processing speed in long-term survivors of childhood cerebellar tumors.

Holly A Aleksonis1, Lisa C Krishnamurthy2,3, Tricia Z King4.   

Abstract

PURPOSE: Across several clinical populations, higher white matter hyperintensity (WMH) burden is consistently associated with decreases in cognitive performance, especially processing speed. Research of childhood cancer survivors has not utilized WMH quantification methodology to better understand the impact of WMH burden and its relationship with core cognitive skills. The present study aimed to quantify WMH volumes in a sample of long-term survivors of childhood cerebellar tumor and investigate the relationships with performance on a measure of oral processing speed. To further explore brain-behavior relationships, multivariate sparse canonical correlations was employed to identify WMH areas that predict processing speed performance.
METHODS: Thirty-five survivors and 56 healthy controls underwent neuroimaging and completed a measure of oral processing speed. The survivor group was further divided based on treatment (i.e., chemoradiation therapy (n = 20) vs. surgery only (n = 15)) to better understand the impact of treatment.
RESULTS: Survivors, and especially those treated with chemoradiation therapy, showed higher total WMH volumes and slower processing speed. Higher total WMH volumes were significantly associated with poorer processing speed (r = - 0.492, p = 0.003). Multivariate brain-behavior relationships revealed that periventricular WMHs were significantly associated with slower processing speed performance (p < 0.05).
CONCLUSION: Results exemplify that long-term survivors treated with and without chemoradiation therapy are at increased risk of developing higher WMH volumes compared to healthy peers. In addition, processing speed was robustly shown to be related to periventricular WMHs using an automated neuroimaging pipeline. This methodology to monitor WMH burden has the potential to be implemented efficiently with routine clinical neuroimaging of cancer survivors.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cerebellum; Neuroimaging; Pediatric brain tumor; Processing speed; Radiation; White matter hyperintensities

Mesh:

Year:  2021        PMID: 34231115     DOI: 10.1007/s11060-021-03799-3

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  20 in total

1.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm.

Authors:  Y Zhang; M Brady; S Smith
Journal:  IEEE Trans Med Imaging       Date:  2001-01       Impact factor: 10.048

Review 2.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

3.  User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability.

Authors:  Paul A Yushkevich; Joseph Piven; Heather Cody Hazlett; Rachel Gimpel Smith; Sean Ho; James C Gee; Guido Gerig
Journal:  Neuroimage       Date:  2006-03-20       Impact factor: 6.556

4.  An optimized blockwise nonlocal means denoising filter for 3-D magnetic resonance images.

Authors:  P Coupe; P Yger; S Prima; P Hellier; C Kervrann; C Barillot
Journal:  IEEE Trans Med Imaging       Date:  2008-04       Impact factor: 10.048

Review 5.  Executive dysfunction in pediatric posterior fossa tumor survivors: a systematic literature review of neurocognitive deficits and interventions.

Authors:  Kelly R Wolfe; Avi Madan-Swain; Rajesh K Kana
Journal:  Dev Neuropsychol       Date:  2012       Impact factor: 2.253

Review 6.  Prevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexate.

Authors:  Wilburn E Reddick; John O Glass; Kathleen J Helton; James W Langston; Xiaoping Xiong; Shengjie Wu; Ching-Hon Pui
Journal:  AJNR Am J Neuroradiol       Date:  2005-05       Impact factor: 3.825

7.  Cerebral white matter integrity and executive function in adult survivors of childhood medulloblastoma.

Authors:  Tara M Brinkman; Wilburn E Reddick; Joshua Luxton; John O Glass; Noah D Sabin; Deo Kumar Srivastava; Leslie L Robison; Melissa M Hudson; Kevin R Krull
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

8.  Cognitive outcome in pediatric brain tumor survivors: delayed attention deficit at long-term follow-up.

Authors:  Marie-Eve Brière; James G Scott; René Y McNall-Knapp; Russell L Adams
Journal:  Pediatr Blood Cancer       Date:  2008-02       Impact factor: 3.167

9.  Volume of white matter hyperintensities is an independent predictor of intelligence quotient and processing speed in children with sickle cell disease.

Authors:  Veronica van der Land; Channa T Hijmans; Marieke de Ruiter; Henri J M M Mutsaerts; Marjon H Cnossen; Marc Engelen; Charles B L M Majoie; Aart J Nederveen; Martha A Grootenhuis; Karin Fijnvandraat
Journal:  Br J Haematol       Date:  2014-10-10       Impact factor: 6.998

10.  Optimized brain extraction for pathological brains (optiBET).

Authors:  Evan S Lutkenhoff; Matthew Rosenberg; Jeffrey Chiang; Kunyu Zhang; John D Pickard; Adrian M Owen; Martin M Monti
Journal:  PLoS One       Date:  2014-12-16       Impact factor: 3.240

View more
  1 in total

1.  An Integrated Analysis of Clinical, Genomic, and Imaging Features Reveals Predictors of Neurocognitive Outcomes in a Longitudinal Cohort of Pediatric Cancer Survivors, Enriched with CNS Tumors (Rad ART Pro).

Authors:  Cassie Kline; Schuyler Stoller; Lennox Byer; David Samuel; Janine M Lupo; Melanie A Morrison; Andreas M Rauschecker; Pierre Nedelec; Walter Faig; Dena B Dubal; Heather J Fullerton; Sabine Mueller
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.